Cite
HARVARD Citation
Sahin, E. et al. (2019). Vulpinic acid, a lichen metabolite, emerges as a potential drug candidate in the therapy of oxidative stress–related diseases, such as atherosclerosis. Human & experimental toxicology. pp. 675-684. [Online].